OrthoAccel Technologies Completes $9M Equity Financing

Published On January 23, 2014 |

OrthoAccel Technologies, Inc., a Houston, Texas-based medical device company, completed a $9m equity financing round.

This included a debt facility for up to $4m with Comerica Bank in November 2013 and a $5m equity financing with HealthpointCapital, S3 Ventures and other stockholders.

The company intends to use the funds to further grow its sales and marketing functions.

Led by Michael K. Lowe, president and CEO, OrthoAccel manufactures AcceleDent®, a FDA-cleared, Class II medical device that accelerates orthodontic tooth movement by applying micropulses as a complement to existing orthodontic treatment.

FinSMEs

23/01/2014

Related News
30/04/2012: OrthoAccel Technologies Raises $10M in Growth Capital

Like this Article? Share it!

Leave a Reply